Breast cancer with multiple parenchymal brain metastases carries an extremely poor outcome. Cranial radiotherapy improves survival by only a few months and the role of systemic therapy is marginal and largely unexplored. We report a patient with recurrent carcinoma of breast presenting with multiple bilateral cervical nodes and brain metastases manifesting as a right hemiparesis and facial nerve palsy, who was treated with palliative whole brain irradiation and letrozole. At the follow up at 20 months, neurological function had fully recovered, and both cerebral and extracerebral lesions had completely resolved, with calcification of the cerebral lesions. This report suggests that letrozole has beneficial effects both in extracranial and intracranial disease in hormone responsive metastatic breast cancer.
Keywords: Breast cancer; brain metastases; letrozole; radiotherapy.
This is a preview of subscription content, log in to check access.
Lien, EA, Wester, K, Lonning, PE, Solheim, E, Ueland, PM 1991Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patientsBr J Cancer63641645PubMedGoogle Scholar
Madhup, R, Kirti, S, Bhatt, ML, Srivastava, PK, Srivastava, M, Kumar, S 2006Letrozole for brain and scalp metastases from breast cancer – a case reportBreast15440442PubMedCrossRefGoogle Scholar
Ozdogan, M, Samur, M, Bozcuk, HS, Sagtas, E, Yildiz, M, Artac, M, Savas, B 2003Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selectionJpn J Clin Oncol33229231PubMedCrossRefGoogle Scholar
Pors, H, von Eyben, FE, Sorensen, OS, Larsen, M 1991Long term remission of multiple brain metastases with tamoxifenJ Neurooncol10173177PubMedCrossRefGoogle Scholar
Rosner, D, Nemoto, T, Lane, WW 1986Chemotherapy induces regression of brain metastases in breast carcinomaCancer58832839PubMedCrossRefGoogle Scholar
Stewart, DJ, Dahrouge, S 1995Response of brain metastases from breast cancer to megestrol acetate: a case reportJ Neurooncol24299301PubMedCrossRefGoogle Scholar